Document Detail

Energetic cost of physical activity in cystic fibrosis children during Pseudomonas aeruginosa pulmonary exacerbation.
MedLine Citation:
PMID:  15681106     Owner:  NLM     Status:  MEDLINE    
Chronic pulmonary infection by Pseudomonas aeruginosa is observed in 50% of patients with cystic fibrosis and requires the use of recurrent intravenous therapy. A decrease of resting energy expenditure (REE) and an increase of physical activity (PA) after intravenous anti-P. aeruginosa therapy (IVAT) is observed while total energy expenditure (TEE) does not change. A decrease in the energetic cost of physical activity (ECPA) could be hypothesized but has never been studied. Our aim was to assess the evolution of ECPA after home IVAT in both standardized condition at hospital and in free-living condition twice before and after IVAT. Sixteen CF patients (nine boys, seven girls) chronically colonized by P. aeruginosa with a mean age of 12.1+/-2.3 years (range 7.1-14.6) were studied before and after IVAT. Each patient passed throughout a visit in hospital: weight, height and fat-free mass were measured. Then, energy expenditure (EE) measured by indirect calorimetry and heart rate (HR) were simultaneously recorded at different levels of PA: REE, and at different intensity of physical activities on a cycloergometer using an incremental increase of the power brake force. Physical activity energy expenditure (PAEE) was computed in laboratory condition using PAEE=EE-BEE (basal energy expenditure). Linear regression between PAEE and power brake force was fitted for each patient before and after IVAT. ECPA in standardized conditions was compared at different range of power brake force using area under the curve (AUC). After coming back at home, 24 h TEE using the heart rate monitoring technique and PA by triaxial accelerometry were simultaneously measured in free-living condition for 24 h during a school day. ECPA in free-living conditions was compared by the ratio PAEE:PA where PAEE=DEE-REE (DEE=daily energy expenditure). After IVAT, median AUC between 60 and 90 W in standardized condition decreased significantly by -15.4% (median 14.9, range 8.8-30.3 vs. median 12.6, range 8.5-17.6; P<0.05, Wilcoxon rank test) while the decrease for lower range of power work load did not reach significance. Spearman correlation was significant between variations of forced expiratory volume in 1 s and variation of AUC at 30-60 W before and after IVAT in standardized condition. In free-living conditions, ratio PAEE/PA did not vary significantly (median 3.4, range 1.6-6.4 vs. median 2.8, range 1.4-4.8; NS). Our data demonstrate a decrease of ECPA after IVAT in standardized conditions for moderate level of PA (60-90 W), but not in free-living conditions. The decrease of ECPA was probably due to a decrease in the energetic cost of breathing after IVAT, that is particularly relevant to promote PA in CF patients.
L Béghin; F Gottrand; L Michaud; H Vodougnon; N Wizla-Derambure; R Hankard; M O Husson; D Turck
Related Documents :
17724456 - Passive cooling to initiate hypothermia for transported encephalopathic newborns.
16135936 - Mortality displacement of heat-related deaths: a comparison of delhi, são paulo, and l...
8957956 - Total energy expenditure and body composition in early infancy.
4084366 - Relationship between maternal and infant nutrition. the special role of fat in energy t...
16390796 - Characteristics of preeclampsia- and eclampsia-related maternal death in rural haiti.
19183116 - Agrichemicals in surface water and birth defects in the united states.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nutrition (Edinburgh, Scotland)     Volume:  24     ISSN:  0261-5614     ISO Abbreviation:  Clin Nutr     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-01-31     Completed Date:  2005-05-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8309603     Medline TA:  Clin Nutr     Country:  England    
Other Details:
Languages:  eng     Pagination:  88-96     Citation Subset:  IM    
Division of Gastroenterology, Hepatology and Nutrition, and Cystic Fibrosis Center, Department of Paediatrics, Jeanne de Flandre University Children's Hospital and Faculty of Medicine, Lille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / administration & dosage,  therapeutic use*
Cystic Fibrosis / complications,  metabolism*
Energy Metabolism / physiology*
Exercise / physiology*
Exercise Test
Predictive Value of Tests
Pseudomonas Infections / drug therapy*
Pseudomonas aeruginosa / metabolism
Respiratory Function Tests
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Distribution of 5,10-methylenetetrahydrofolate reductase (C667T) polymorphism and its association wi...
Next Document:  Minimal sampling protocol for accurate estimation of urea production: a study with oral [13C]urea in...